Relationship between metabolic remodeling of pancreatic β-cells and pancreatic histology in type 2 diabetes
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgag315 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Rimi Izumihara und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8638,…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin-Secreting Cells, Phosphofructokinase-2, Pancreas. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Grants-in-Aid for Young Scientists, Scientific Research, Ministry of Education, Culture, Sports, Science, and Technology of Japan.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) is a key glycolytic regulator involved in the compensation for β-cell dysfunction under diabetic conditions, but its upstream regulation is incompletely understood. Here, we have characterized the relationship between the underlying pancreatic pathology and PFKFB3 expression in pancreatic β-cells.
Methods
Pancreatic sections from deceased individuals with and without type 2 diabetes (T2D) were immunostained for PFKFB3. The ratios of PFKFB3-positive β and α cells were compared, and the relationships with islet amyloid and pancreatic fibrosis were assessed. PFKFB3 expression was also evaluated in caerulein-treated mice and INS-1 832/13 cells co-cultured with pancreatic stellate cells (PSCs), as models of fibrosis.
Results
Eighteen individuals with and 18 without T2D were evaluated. The proportion of PFKFB3-positive β-cells, but not α-cells, was higher in those with T2D (23.9% ± 16.1% vs 8.7% ± 6.3%, P < .05). PFKFB3 expression negatively correlated with β-cell mass (ρ = −0.34, P < .05). Both the amyloid deposition and area of fibrosis positively correlated with the proportion of PFKFB3-positive β-cells (ρ = 0.50 and 0.84, respectively; P < .05). In mice, β-cell PFKFB3 positivity was higher in the fibrosis model vs controls (20.5% ± 10.5% vs 5.6% ± 5.1%, P < .05). Additionally, Pfkfb3 expression in INS-1 cells was significantly higher after co-culture with PSCs. In this co-culture model, RNA sequencing identified transforming growth factor (TGF)-β-related gene clusters; enzyme-linked immunosorbent assay confirmed high TGF-β levels, and western blotting showed greater phosphorylation of Smad.
Conclusion
PFKFB3-mediated metabolic remodeling occurs in the β-cells of individuals with T2D, and is linked not only to β-cell overload, but to pancreatic fibrosis and local TGF-β/Smad signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Japan.
- Division of Endocrinology, Metabolism, and Rheumatology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa 078-8510, Japan.
- Department of Pathology and Molecular Medicine, Biomedical Research Center, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan.
ORCID-Profile: Rimi Izumihara, Hiroshi Nomoto, Hiraku Kameda, Akinobu Nakamura, Hiroki Mizukami, Tatsuya Atsumi
Förderung
- Grants-in-Aid for Young Scientists
- Scientific Research
- Ministry of Education, Culture, Sports, Science, and Technology of Japan
- Japan Diabetes Society Junior Scientist Development Grant
- Novo Nordisk Pharma Ltd.
- MSD Life Science Foundation
- Public Interest Incorporated Foundation
Zitieren
APA
Izumihara, R., Nomoto, H., Chiba, K., Kameda, H., Nakamura, A., Mizukami, H., & Atsumi, T. (2026). Relationship between metabolic remodeling of pancreatic β-cells and pancreatic histology in type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag315
Vancouver
Izumihara R, Nomoto H, Chiba K, Kameda H, Nakamura A, Mizukami H, et al. Relationship between metabolic remodeling of pancreatic β-cells and pancreatic histology in type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag315
BibTeX
@article{Izumihara2026,
author = {Izumihara, Rimi and Nomoto, Hiroshi and Chiba, Koki and Kameda, Hiraku and Nakamura, Akinobu and Mizukami, Hiroki and Atsumi, Tatsuya},
title = {Relationship between metabolic remodeling of pancreatic β-cells and pancreatic histology in type 2 diabetes},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgag315}
}
EUVIMED